ASX - Delayed Quote AUD

Control Bionics Limited (CBL.AX)

Compare
0.0570
-0.0040
(-6.56%)
As of 2:43:09 PM GMT+11. Market Open.
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
5,126.8970
5,126.8970
5,435.1910
4,380.2200
3,928.7950
Cost of Revenue
1,454.1210
1,454.1210
1,930.7910
1,977.8740
1,429.9550
Gross Profit
3,672.7760
3,672.7760
3,504.4000
2,402.3460
2,498.8400
Operating Expense
10,762.9150
10,762.9150
9,790.3670
9,009.5610
6,584.5220
Operating Income
-7,090.1390
-7,090.1390
-6,285.9670
-6,607.2150
-4,085.6820
Net Non Operating Interest Income Expense
-44.1000
-44.1000
-1.1910
-41.6670
-69.2150
Other Income Expense
1,220.4600
1,220.4600
656.0170
547.6580
604.0710
Pretax Income
-5,913.7790
-5,913.7790
-5,631.1410
-6,101.2240
-3,550.8260
Net Income Common Stockholders
-5,913.7790
-5,913.7790
-5,631.1410
-6,101.2240
-3,550.8260
Basic EPS
-0.04
--
-0.06
-0.06
-0.05
Diluted EPS
-0.04
--
-0.06
-0.06
-0.05
Basic Average Shares
159,393.2900
--
100,050.9760
94,562.5040
69,513.0070
Diluted Average Shares
159,393.2900
--
100,050.9760
94,562.5040
69,513.0070
Net Income from Continuing & Discontinued Operation
-5,913.7790
-5,913.7790
-5,631.1410
-6,101.2240
-3,550.8260
Normalized Income
-5,913.7790
-5,913.7790
-5,631.1410
-6,101.2240
-3,550.8260
Interest Income
12.1830
12.1830
20.1410
1.3270
1.1610
Interest Expense
56.2830
56.2830
12.3100
8.8870
32.7790
Net Interest Income
-44.1000
-44.1000
-1.1910
-41.6670
-69.2150
EBIT
-5,857.4960
-5,857.4960
-5,618.8310
-6,092.3370
-3,518.0470
EBITDA
-5,014.3050
-5,014.3050
-5,138.3810
-5,584.4860
-3,319.5130
Reconciled Cost of Revenue
1,454.1210
1,454.1210
1,930.7910
1,977.8740
1,429.9550
Reconciled Depreciation
843.1910
843.1910
480.4500
507.8510
198.5340
Net Income from Continuing Operation Net Minority Interest
-5,913.7790
-5,913.7790
-5,631.1410
-6,101.2240
-3,550.8260
Normalized EBITDA
-5,014.3050
-5,014.3050
-5,138.3810
-5,584.4860
-3,319.5130
6/30/2021 - 12/6/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

COV.AX Cleo Diagnostics Ltd
0.3550
0.00%
 
CSX.AX CleanSpace Holdings Limited
0.4350
0.00%
 
CMP.AX Compumedics Limited
0.2850
-5.00%
 
CVB.AX CurveBeam AI Limited
0.1100
+10.00%
 
EMV.AX EMVision Medical Devices Ltd
1.8100
0.00%
 
EYE.AX Nova Eye Medical Limited
0.1450
-12.12%
 
CDX.AX CardieX Limited
0.1250
-7.41%
 
AT1.AX Atomo Diagnostics Limited
0.0190
+5.56%
 
AVR.AX Anteris Technologies Global Corp.
9.25
+2.78%
 
EBR.AX EBR Systems, Inc.
1.6800
0.00%